Brief: Innovative Pharmaceutical Biotech says FY revenue HK$9.2 mln vs HK$19.9 mln
June 30 (Reuters) - Innovative Pharmaceutical Biotech Ltd
0399.HK :
* FY revenue HK$9.2 million versus HK$19.9 million
* FY loss for year attributable to owners of company
HK$169.8 million versus loss of HK$236.9 million
Source text: (http://bit.ly/2tuQThY)
Further company coverage: 0399.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU